Role of glutathione in reduction of arsenate and of γ-glutamyltranspeptidase in disposition of arsenite in rats

被引:31
作者
Csanaky, I [1 ]
Gregus, Z [1 ]
机构
[1] Univ Pecs, Sch Med, Dept Pharmacol & Pharmacotherapy, Toxicol Sect, H-7643 Pecs, Hungary
基金
匈牙利科学研究基金会;
关键词
arsenic; biliary excretion; urinary excretion; glutathione; gamma-glutamyltranspeptidase; buthionine sulfoximine; acivicin;
D O I
10.1016/j.tox.2004.09.002
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Arsenate (AsV), the environmentally prevalent form of arsenic, is converted sequentially in the body to arsenite (AsIII). monomethylarsonic acid (MMAsV), monomethylarsonous acid (MMAsIII), and dimethylarsinic acid (DMAsV) and some, trimethylated metabolites. Although the biliary excretion of arsenic in rats is known to be glutathione (GSH)-dependent. involving transport of arsenic-GSH conjugates. the role of GSH in the reduction of AsV to the more toxic AsIII in vivo has not been defined. Therefore, we studied how the fate of AsV is influenced by buthionine sulfoximine (BSO), which depletes GSH in tissues. Control and BSO-treated rats were given AsV (50 mumol/kg. i.v.) and arsenic metabolites in bile. urine. blood and tissues were analysed by HPLC-HG-AFS. BSO increased retention of AsV in blood and tissues and decreased appearance of AsIII in blood, bile (by 96%) and urine (by 63%). The biliary excretion of NMAsIII was also nearly abolished, the appearance of MMAsIII and MMAsV in the blood was delayed and the renal concentrations of these monomethylated arsenicals were decreased by BSO. Interestingly, appearance of DMAsV in blood and urine remained unchanged and the concentrations of this metabolite in the kidneys and muscle were even increased in response to BSO. To test the role of gamma-glutamyltranspeptidase (GGT) in arsenic disposition. the effect of the of the GGT inhibitor acivicin was investigated in rats injected with AsIII (50 mumol/kg. i.v.). Acivicin lowered the hepatic and renal GGT activities and increased the biliary as well as urinary excretion of GSH, but failed to alter the disposition (i.e. blood and tissue concentrations. biliary and urinary excretion) of AsIII and its metabolites. In conclusion, shortage of GSH decreases not only the hepatobiliary transport of arsenic, but also reduction of AsV and the formation of monomethylated arsenic. while not hindering the production of dimethylated arsenic. While GSH plays an important role in the disposition and toxicity of arsenic. GGT, which hydrolyses GSH and GSH conjugates, apparently does not influence the fate of the GSH-reactive trivalent arsenicals in rats. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:91 / 104
页数:14
相关论文
共 55 条
[1]
ALBERT Z, 1964, ACTA HISTOCHEM, V18, P78
[2]
ALLEN L, 1980, RES COMMUN CHEM PATH, V27, P175
[3]
Ballatori N, 1998, AM J PATHOL, V152, P1049
[4]
CELLULAR UPTAKE AND METABOLIC REDUCTION OF PENTAVALENT TO TRIVALENT ARSENIC AS DETERMINANTS OF CYTOTOXICITY AND MORPHOLOGICAL TRANSFORMATION [J].
BERTOLERO, F ;
POZZI, G ;
SABBIONI, E ;
SAFFIOTTI, U .
CARCINOGENESIS, 1987, 8 (06) :803-808
[5]
STUDY OF FACTORS INFLUENCING THE INVIVO METHYLATION OF INORGANIC ARSENIC IN RATS [J].
BUCHET, JP ;
LAUWERYS, R .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 91 (01) :65-74
[6]
Effect of selenite on the disposition of arsenate and arsenite in rats [J].
Csanaky, I ;
Gregus, Z .
TOXICOLOGY, 2003, 186 (1-2) :33-50
[7]
Dose-dependent biotransformation of arsenite in rats -: not S-adenosylmethionine depletion impairs arsenic methylation at high dose [J].
Csanaky, I ;
Németi, B ;
Gregus, Z .
TOXICOLOGY, 2003, 183 (1-3) :77-91
[8]
Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats [J].
Csanaky, I ;
Gregus, Z .
TOXICOLOGICAL SCIENCES, 2001, 63 (01) :29-36
[9]
Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites [J].
Csanaky, L ;
Gregus, Z .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2002, 131 (03) :355-365
[10]
Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system [J].
Dai, J ;
Weinberg, RS ;
Waxman, S ;
Jing, YK .
BLOOD, 1999, 93 (01) :268-277